Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

Cp Tianqing plans to sell three subsidiaries

Cp Tianqing plans to sell three subsidiaries

2022-12-23

Nanjing Pharmaceutical plans to acquire part or all of CP Tianqing's three controlling subsidiaries.

Reindeer Biological self - developed CT103A clinical trial application approved by FDA!

Reindeer Biological self - developed CT103A clinical trial application approved by FDA!

2022-12-23

The approval of the CT103A US IND is an important milestone in the internationalization of reindeer biology.

Kangvanda's first oncolytic vaccinia virus product V01 clinical application accepted
Fosun Kat FKC889 was approved for clinical trials

Fosun Kat FKC889 was approved for clinical trials

2022-12-23

For the treatment of relapsed or refractory adult precursor B-cell acute lymphoblastic leukemia.

Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species

Eu assessment of the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species

2022-12-22

After assessment, the Panel was unable to reach a conclusion on the efficacy of Bacillus Velez NRRL B-67259 as a feed additive for all growing poultry species.

The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens

The European Union evaluates the safety of Lasaloxi sodium as a feed additive for fattening and laying hens

2022-12-22

European Union animal Feed Additives and Products (FEEDAP) research group issued A scientific opinion on the safety of lasalocid A sodium asa dietary additive for fattening chickens and laying hens.

National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching

National Medical Insurance Administration held a meeting, anti-epidemic drugs will be reduced again! Health care negotiations are approaching

2022-12-22

We will do a good job in medical insurance at the end of the year and the beginning of the year, steadily advance the centralized procurement of dental implant consumables, and complete the adjustment of the 2022 medical insurance drug list.

Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted

Phase II enrollment of ASC41(THRβ), an innovative pipeline drug developed by Lilly NASH, was successfully promoted

2022-12-22

Asc 41 is a liver targeting precursor drug independently developed by Golly.

ASKG915 for Injection, a subsidiary of AskG915, was approved in the US
Advanced liver cancer treatment new progress! The oncolytic virus drug VG161 has remarkable clinical effect
Fubicide vaccine was approved for official registration in Hong Kong, China

Fubicide vaccine was approved for official registration in Hong Kong, China

2022-12-22

Fubicide vaccine has better immunogenicity and broad spectrum.

What if you can't get acetaminophen?

What if you can't get acetaminophen?

2022-12-22

It is also the main ingredient in many cold remedies.

Clover Liang Peng: How to bring the patented technology 'home' to achieve the dark horse of COVID-19 vaccine?

Clover Liang Peng: How to bring the patented technology 'home' to achieve the dark horse of COVID-19 vaccine?

2022-12-22

With this discovery, he established the past and future of clover life.

Junsil Biologics has opened new VV116 and Pfizer Paxlovid head-to-head phase III clinical trials

Junsil Biologics has opened new VV116 and Pfizer Paxlovid head-to-head phase III clinical trials

2022-12-22

The development of "special drugs" for COVID-19 has entered the fast track again.

Can PROTAC Grab a slice of the $50 billion market for self-medicated drugs?
Merck's new generation of antifungal drug Posaconazole inJ has been launched in China

Merck's new generation of antifungal drug Posaconazole inJ has been launched in China

2022-12-22

It is used to prevent invasive aspergillus and candida infection and to treat invasive aspergillus disease.

Pfizer and LianBio have entered into a collaboration agreement on respiratory syncytial virus therapeutic candidates

Pfizer and LianBio have entered into a collaboration agreement on respiratory syncytial virus therapeutic candidates

2022-12-20

Pfizer and LianBio have reached a collaboration agreement on respiratory syncytial virus treatment candidates.

Hutchison Pharmaceutical: Fruquintinib submitted a rolling marketing application to the FDA

Hutchison Pharmaceutical: Fruquintinib submitted a rolling marketing application to the FDA

2022-12-20

Hutchison Pharma owns all commercialization rights of fruquintinib outside of China.

Nearly $4 billion in gambling, revealing the top ten licenses in 2022

Nearly $4 billion in gambling, revealing the top ten licenses in 2022

2022-12-19

Under the capital winter, the cross-border license in of domestic pharmaceutical companies has also been affected to a certain extent.

Can the concept of 'new crown miracle drug' ursodeoxycholic acid set off a new round of research and development?
  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message